Comparative effectiveness in pain and haq-di improvement for baricitinib versus adalimumab, tocilizumab, and tofacitinib monotherapies in csdmard-naÏve rheumatoid arthritis patients: a matching-adjusted indirect comparison (MAIC) - Fautrel, B; Zhu, B; Taylor, P; van de Laar, M; Emery, P; De Leonardis, F; Gaich, C; Nicolay, C; Kadziola, Z; De La Torre, I; Fleischmann, R (BMJ Publishing Group, 2018)